These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1347328)

  • 1. [Investigation of the therapeutic use of proton pump inhibitor (PPI) by measurement of 24 hour the intra-gastric pH].
    Yamagata S
    Nihon Rinsho; 1992 Jan; 50(1):160-6. PubMed ID: 1347328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
    Asaki S; Kimpara T; Ohara S; Hongo M
    Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [H2-receptor antagonist-refractory ulcer--its pathophysiology and role of proton-pump inhibitors].
    Arakawa T
    Nihon Rinsho; 1992 Jan; 50(1):122-30. PubMed ID: 1347325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].
    Ivanov AN; Iakovenko EP; Iakovenko AV
    Eksp Klin Gastroenterol; 2004; (4):16-20, 107. PubMed ID: 15568661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristic features of proton pump inhibitors in the inhibition of gastric acid secretion: long-acting and complete inhibition].
    Ohe K
    Nihon Rinsho; 1992 Jan; 50(1):45-52. PubMed ID: 1311789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M; Kato M; Sato Y; Miyazaki T
    Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
    Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-pharmacological evaluation of omeprazole, as a proton pump inhibitor, compared with H2-blockers].
    Nakashima M; Kanamaru M
    Nihon Rinsho; 1992 Jan; 50(1):60-7. PubMed ID: 1347331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omeprazole on regional and temporal variations in intragastric acidity.
    Viani F; Verdú EF; Idström JP; Cederberg C; Fraser R; Fried M; Blum AL; Armstrong D
    Digestion; 2002; 65(1):2-10. PubMed ID: 11961336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a proton pump inhibitor AG-1749 (lansoprazole) on intragastric pH: 24-hour intragastric pH monitoring].
    Kihira K; Yoshida Y; Kasano T; Taniguchi Y; Sato K; Kimura K; Hirose M; Koyama H
    Nihon Shokakibyo Gakkai Zasshi; 1991 Mar; 88(3):672-80. PubMed ID: 1646341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of proton pump inhibitor to special conditions; Zollinger-Ellison syndrome].
    Tani N
    Nihon Rinsho; 1992 Jan; 50(1):154-9. PubMed ID: 1347327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
    Yoshino J; Nakazawa S; Nakamura T; Yamao K; Inui K; Yamachika H; Watanabe K; Wakabayashi T
    Nihon Rinsho; 1992 Jan; 50(1):81-5. PubMed ID: 1347334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring.
    Palasciano G; Maggi V; Portincasa P
    Ital J Gastroenterol; 1990 Oct; 22(5):291-4. PubMed ID: 1983712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proton pump inhibitors: their merits and demerits, and perspectives for future investigation].
    Kamada T; Kawano S; Tsuji S
    Nihon Rinsho; 1992 Jan; 50(1):53-9. PubMed ID: 1347330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the intracellular pharmacodynamic properties of proton pump inhibitors and the inhibitory mechanism of acid secretion].
    Saito E; Matsuo Y
    Nihon Rinsho; 1992 Jan; 50(1):18-25. PubMed ID: 1311783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of proton pump inhibitors on reflux esophagitis].
    Sekiguchi T; Horikoshi T; Nishioka T; Kusano M
    Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.